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Abstract
Background: For a long time IBs were considered to be inactive deposits of accumulated target
proteins. In our previous studies, we discovered IBs containing a high percentage of correctly
folded protein that can be extracted under non-denaturing conditions in biologically active form
without applying any renaturation steps. In order to widen the concept of correctly folded protein
inside IBs, G-CSF (granulocyte colony stimulating factor) and three additional proteins were chosen
for this study: GFP (Green fluorescent protein), His7dN6TNF-α ( T r u n c a t e d  f o r m  o f  T u m o r
necrosis factor α with an N-terminal histidine tag) and dN19 LT-α (Truncated form of
Lymphotoxin α).
Results: Four structurally different proteins that accumulate in the bacterial cell in the form of IBs
were studied, revealing that distribution of each target protein between the soluble fraction
(cytoplasm) and insoluble fraction (IBs) depends on the nature of the target protein.
Irrespective of the folding pattern of each protein, spectroscopy studies have shown that proteins
in IBs exhibit similar structural characteristics to the biologically active pure protein when
produced at low temperature. In the case of the three studied proteins, G-CSF, His7ΔN6TNF-α,
and GFP, a significant amount of protein could be extracted from IBs with 0.2% N-lauroyl sarcosine
(NLS) and the proteins retained biological activity although no renaturation procedure was applied.
Conclusion: This study shows that the presence of biologically active proteins inside IBs is more
general than usually believed. A large amount of properly folded protein is trapped inside IBs
prepared at lower temperatures. This protein can be released from IBs with mild detergents under
non-denaturing conditions. Therefore, the active protein can be obtained from such IBs without
any renaturation procedure. This is of great importance for the biopharmaceutical industry.
Furthermore, such IBs composed of active proteins could also be used as pure nanoparticles in
diagnostics, as biocatalysts in enzymatic processes, or even as biopharmaceuticals.
Published: 1 December 2008
Microbial Cell Factories 2008, 7:34 doi:10.1186/1475-2859-7-34
Received: 23 September 2008
Accepted: 1 December 2008
This article is available from: http://www.microbialcellfactories.com/content/7/1/34
© 2008 Peternel et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Microbial Cell Factories 2008, 7:34 http://www.microbialcellfactories.com/content/7/1/34
Page 2 of 9
(page number not for citation purposes)
Background
The formation of inclusion bodies (IBs) upon overexpres-
sion of heterologous proteins in Escherichia coli (E. coli) is
a common event. Because of the belief that IBs are intrac-
ellular deposits of misfolded, biologically inactive pro-
teins, they have been considered to be a bottleneck in
protein production. To avoid time consuming and often
unfavorable renaturation procedures, a lot of effort has
been made to produce soluble proteins in bacteria either
by altering the production process [1,2], by co-expression
of chaperones [3,4] or by altering the target protein (point
mutations, fusion proteins) [5,6]. In the last few years, the
view of inclusion bodies has been changing. The first
observations of enzymatic activity in proteins inside IBs
[7,8] were reported more than 15 years ago, but the phe-
nomenon was not further explored and the usefulness
and biotechnological importance were not recognized.
Recently, several groups have reported the presence of
biologically active proteins inside IBs [9-12]. The presence
of residual native-like structures detected by Fourier trans-
form infrared (FT-IR) spectroscopy has been reported by
several authors [13,14].
Previous studies in our laboratory revealed an interesting
type of inclusion bodies containing a high percentage of
correctly folded protein precursor trapped inside (non-
classical IBs – ncIBs). For fermenter cultivation, Jevsevar at
al. [12] reported more than 40% activity of granulocyte
colony stimulating factor (G-CSF) extracted from ncIBs
under non-denaturing conditions, whereas in the shake
flask culture the percentage of biologically active G-CSF
was even higher [11]. Therefore the research was
expanded to other structurally unrelated proteins that all
form inclusion bodies upon overexpression in E. coli. In
addition to human granulocyte colony stimulating factor
(G-CSF), green fluorescent protein (GFP), N-truncated
form of tumor necrosis factor α bearing an N-terminal his-
tidine tag (His7ΔN6TNF-α), and N-truncated form of
Lymphotoxin α (ΔN19LT-α) were studied.
As was previously already reported for diverse proteins by
several authors [12,15-17] we also demonstrate that the
production of IBs at low temperature results in a higher
amount of correctly folded proteins trapped inside IBs.
This work is aimed at exploring whether the amount of
correctly folded protein trapped in IBs is protein specific.
Increased solubility in low concentration detergents was
also studied. Solubility of inclusion bodies in mild deter-
gents under non-denaturing conditions enables the
extraction of the target protein in biologically active form
without any denaturation and renaturation process. This
is an interesting, and for downstream processes very
important, property.
Methods
Strains and plasmids
Recombinant E. coli production strain BL21(DE3) (Nova-
gen) was used in this study along with expression plas-
mids pET3a, pET19b (Novagen), and pQT2 (Qiagen)
coding four structurally different proteins.
Details about the production of the BL21(DE3) [pET3a/P-
Fopt5] strain for G-CSF production were described by Jev-
sevar et al. [12].
Human lymphotoxin alpha (LT α) from plasmid BBG 5
(R&D Systems) was amplified and truncated by PCR. The
truncated form of LT α (lacking the first 19 amino acids:
M1LPGVGLTPSAAQTARQHPK20) was subcloned into the
pET19b plasmid (Novagen) between the NdeI and BspHI
restriction sites. Plasmid pET19b-dN19 LT-α was then
transformed into the E. coli BL21(DE3) production strain.
Synthetic human tumor necrosis factor alpha (TNF α)
with E. coli optimized codons was obtained from British
Biotechnology. The N-terminus was truncated (deletion
of the first six amino acids: V1RSSSR6) and amplified by
PCR. The deleted protein was than subcloned into the
pQE-TAGZyme-2 plasmid (pQT2 – Qiagen), which
encodes for the His 7 affinity tag, between the restriction
sites SphI and HindIII [18]. Plasmid pQT2-dN6 TNFα was
then transformed into the E. coli BL21(DE3) production
strain.
Green fluorescent protein (GFP) from plasmid pGFP
(Clontech) was amplified by PCR and subcloned into the
pET19b plasmid between the restriction sites XhoI and
NcoI. Plasmid pET19b-GFP was then transformed into the
E. coli BL21(DE3) production strain.
Medium
LBG/amp 100 medium: 10 g/l BBL Phytone Peptone (Bec-
ton Dickinson), 5 g/l Bacto Yeast extract (Becton Dickin-
son), 10 g/l NaCl (Sigma), 100 mg/l ampicillin (Sigma),
and 2.5 g/l glucose (Sigma).
GYSP/amp 100 medium: 20 g/l BBL Phytone Peptone
(Becton Dickinson), 5 g/l Bacto Yeast extract (Becton
Dickinson), 10 g/l NaCl (Sigma), 10 g/l glucose (Sigma),
trace elements (FeSO47H2O (40 mg/l), CaCl22H2O (40
mg/l), MnSO4nH2O (10 mg/l), AlCl36H2O (10 mg/l),
CoCl26H2O (4 mg/l), ZnSO47H2O (2 mg/l),
NMoO42H2O (2 mg/l), CuSO45H2O (1 mg/l),
H3BO3(0.5 mg/l)), and 100 mg/l ampicillin (Sigma).
Inducer: 0.4 mM IPTG (Sigma).Microbial Cell Factories 2008, 7:34 http://www.microbialcellfactories.com/content/7/1/34
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Culture conditions
Initial bacterial inoculum was prepared in a shake flask
culture and grown overnight at 25°C at 160 rpm on the
LBG/amp 100 medium. It was then transferred to the
GYSP/amp 100 medium and induced with IPTG (imme-
diate induction). The shake flask cultures were incubated
at 160 rpm and 25°C, 37°C, and 42°C independently
(Kühner linear shaker) until the culture reached the sta-
tionary phase. After production, the biomass was aliq-
uoted, centrifuged, and the supernatant was discarded.
The bacterial pellet was stored for further analysis.
Isolation of inclusion bodies
The bacterial pellet was resuspended in 50 mM Tris/HCl,
containing 30 mM NaCl. The high-pressure homogenizer
Emulsiflex® – C5 (Avestin) was used for cell disruption
(operating pressure 75 – 100 MPa); several passages were
made. The homogenate was centrifuged at 10,000 g. The
supernatant (soluble protein fraction; SN1) was stored for
analysis. The pellet of IBs (P1) was washed twice with
pure water and used for further analysis.
Distribution of target protein between cytoplasm and IBs
The bacterial pellet, separated cell fractions after cell dis-
ruption (SN1, P1), and samples gathered after extraction
of target protein from IBs (SN2, P2) were analyzed by
SDS-PAGE. Gels were analyzed densitometrically with a
ProExpress Imaging System (Perkin Elmer).
Infrared analysis
The proteins were prepared in a solution, as highly
hydrated ammonium sulfate precipitate and as IBs pre-
pared at three various growth temperatures (25, 37,
42°C). Washed IBs, as well as ammonium sulfate precip-
itates, were dried in a Savant DNA Speed-Vac system for
one-hour prior to analysis to reduce water interference in
the infrared spectra. The infrared spectra of protein sam-
ples were recorded on a Bruker IFS66S spectrometer
equipped with liquid nitrogen cooled MTC detector and
Golden-Gate ATR diamond cell. The infrared spectra were
used mainly for monitoring the deviations in structures of
proteins prepared at different temperatures with respect to
properly folded ones. Therefore, the effects of reflection
were neglected and the ATR spectra were used as recorded
with no additional corrections. Typically, 64 scans were
averaged at a resolution of 4 cm-1 and apodized with a tri-
angular function. Solvent spectra were recorded and sub-
tracted before the examination of the amide I bands. The
structures of the amide I and amide II regions were ana-
lyzed by second derivatives and Fourier deconvolution.
The derivative spectra were smoothed by the
Savitzky_Golay algorithm applying the 3rd polynomial
and 15 smoothing points and normalized on the Tyrosine
band near 1517 cm-1. The spectra were processed applying
the Grams software package.
Extractability of inclusion bodies
The wet IBs pellet (P1) was resuspended with solubilizing
buffer (40 mM Tris/HCl with 0.2% N-lauroyl sarcosine,
pH 8.0) at a ratio of 1:40. The suspension was shaken for
24 hours at 20°C and centrifuged at 4400 g for 15 min-
utes. The supernatant (solubilized target protein from IBs;
SN2) and pellet (insoluble fraction of IBs; P2), as well as
the supernatant SN1 and pellet P1 (chapter 2.2 Prepara-
tion of washed inclusion bodies) were analyzed by SDS-
PAGE. The target protein was determined densitometri-
cally as a fraction of the total proteins by profile analysis
using a BIO-RAD imaging densitometer – model GS-670.
Supernatants were further used for biological activity
measurements.
Biological activity
The biological activity of G-CSF was measured via prolif-
eration activity on the murine myeloblastic NFS-60 cell
line [19].
The biological activity of TNF α and LT α was measured
via the specific cytotoxic activity on the mouse fibroblast
L929 cell line [20,21].
The biological activity of all proteins was measured in two
distinctive fractions: in the supernatant (soluble protein
produced in the cytoplasm; SN1) and in IBs solubilized
with 0.2% N-lauroyl sarcosine (SN2). All the samples
were filtered through 0.22 μm centrifuge cellulose acetate
filters (Costar SPIN-X™) before testing. Average specific
activity of the proteins inside the cell fraction is presented
as the result.
Fluorescence
In the case of GFP, fluorescence was taken as a sign of a
correctly folded and oxidized protein. The fluorescence
spectrum of GFP soluble in the cytoplasm (SN1) as well as
of GFP extracted from IBs (SN2) was compared to the
spectrum of an in-house GFP standard isolated and puri-
fied in our laboratory.
The fluorescence of soluble GFP and GFP extracted from
IBs with 0.2% N-lauroyl sarcosine (SN2) was measured
on a QuantaMaster C-61 Spectrofluorometer (Photone
Technology International).
Results and Discussion
Distribution of target protein between cytoplasm and IBs
The protein yield of all four proteins, G-CSF, GFP,
His7ΔN6TNF-α, and ΔN19LT-α, was relatively high, as
target proteins represent 35–45% of total cell proteins
(Table 1). All four proteins form inclusion bodies, but the
distribution of the target protein between the soluble
form in the cytoplasm and the aggregated form of IBs
depends on the protein.Microbial Cell Factories 2008, 7:34 http://www.microbialcellfactories.com/content/7/1/34
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Many environmental factors influence the formation of
IBs but predicting whether the target protein will accumu-
late as a soluble or insoluble fraction in the cell is still
almost impossible, since this is dependent on the
polypeptide and its sequence [22]. Even changing only
one amino acid in the polypeptide sequence can drive a
formerly soluble protein to aggregate in the IBs [23].
In the case of G-CSF, almost all protein is found in IBs. As
already reported, the amount of correctly folded protein
inside the IBs strongly depends on the growth tempera-
ture [12], with growth at a low temperature of 25°C
resulting into the highest percentage of correctly folded
protein.
In contrast, at low growth temperatures, fluorescent GFP
(correctly folded and oxidized) was found to be soluble to
a large extent in the E. coli cytoplasm (data not shown).
However, using a bacterial host with a strong promoter, it
was possible to force the formation of fluorescent IBs.
Although native trimeric TNF-α is produced well as solu-
ble product in E. coli cytoplasm [20], the addition of a his-
tidine affinity tag to the truncated form of TNF-α
(His7ΔN6 TNF-α) causes some formation of IBs. How-
ever, the majority of the protein still remains soluble in
cytoplasm.
On the other hand native LT-α, also known as TNF-β, is a
trimeric cytokine very similar to TNF-α, but appears in
both soluble and IBs form (data not shown), while the
truncated form (dN19 LT-α) occurs predominantly as
insoluble IBs (Table 1).
Infrared studies
The secondary structures of the proteins inside IBs were
examined by infrared spectroscopy. The frequency and the
shape of the amide I bands in the spectral region between
1690 and 1620 cm-1 are sensitive to different types of pro-
tein secondary structure [24]. A band analysis of the
amide I region, retrieves accurate information about pro-
tein secondary structure [25]. However, the components
of the amide I band, which belong to different secondary
structure elements, are strongly overlapped. To extract
these components, second derivatives and Fourier decon-
volution were applied. Both mathematical approaches
give an almost identical intrinsic band structure in the
amide I region, so solely the results of the second derivates
are presented.
The presence of a large amount of correctly folded hG-CSF
protein inside IBs prepared at low temperature was con-
firmed by infrared spectroscopy [12]. At higher tempera-
tures (37°C, 42°C), the infrared spectra of IBs revealed
red shifts of the maxima and different shapes pointing to
different structures and intermolecular associations of
proteins inside the IBs.
Although the protein folding of G-CSF is completely dif-
ferent from GFP, His7ΔN6TNF-α or ΔN19LT-α, even for
these proteins the highest amount of correctly folded
structure inside the IBs was found when the bacterium
growth was performed at relatively low temperatures.
Infrared spectra of highly purified GFP and His7ΔN6TNF-
α protein solutions, as well as of ammonium sulfate pre-
cipitates (ASP) of the pure proteins, were recorded and
compared to the infrared spectra of isolated IBs prepared
at different cultivation temperatures. ASP represents the
correctly folded solid form of the pure protein as was
proven by biological activity measurements after precipi-
tate dissolution [12].
As pure GFP in solution tends to aggregate at high concen-
trations, the IBs samples were compared to the ASP of
pure GFP (Figure 1). The second derivative spectra in the
amide I and amide II regions are presented in Figure 2.
The distinctive bands characteristic for β-structure [26,27]
can be found at 1627 cm-1 and 1686 cm-1. The original, as
well as the secondary derivative spectra of IBs prepared at
25°C and 37°C are very similar to the spectrum of the
pure protein. In contrast, the spectrum of the IBs prepared
at 42°C possesses several differences. The most pro-
nounced one is the decrease in the intensity of the band at
1627 cm-1 while the intensity of the band at 1650 cm-1,
characteristic for unordered protein structure [26],
increases.
The structure and frequencies of band components of the
amide I region in the infrared spectrum of pure His7ΔN6
TNF-α confirmed the predominantly β structure of the
Table 1: Protein yield of target proteins inside bacterial cells is presented, as well as the distribution of target protein between soluble 
and insoluble cell fraction.
Target protein % of target protein in total proteins (protein yield) % of protein in insoluble fraction (IBs) with respect to total target protein
G-CSF 38 98
GFP 45 77
His7dN6TNF-α 39 40
dN19LT-α 35 91Microbial Cell Factories 2008, 7:34 http://www.microbialcellfactories.com/content/7/1/34
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protein (Figure 3 and Figure 4). The bands of the ASP of
the pure protein moves slightly towards the 1620 cm-1
characteristic for intermolecular β-sheet connections [28].
Upon resuspension, the ASP biological activity of the pro-
tein remains unchanged (data not shown), thus no
change in the protein structure is expected to occur in ASP.
IBs prepared at 37°C show the same spectrum as the ASP,
while the spectra of the IBs prepared at 25°C and 42°C
have an additional band at 1650 cm-1 characteristic for
unordered protein structure [26].
For ΔN19LT-α, only spectra of IBs prepared at different
temperatures were recorded since the protein is very
hydrophobic and aggregates at high concentrations.
ΔN19LT-α has a predominant β-structure that can be seen
from the original (Figure 5) and second derivative spectra
(Figure 6) of IBs displaying peaks at 1627 cm-1 and 1685
cm-1 [26,27]. The infrared spectra of IBs prepared at differ-
ent growth temperatures differ from each other. Especially
prominent is the increase in the intensity of the band at
1650 cm-1 caused by the elevation of the preparation tem-
perature. This change in band intensity implies an
increase in the unordered structure inside IBs with respect
to those prepared at lower temperatures
FT-IR spectra in Amide I and Amide II regions of ammonium  sulfate precipitate of pure GFP (b), and inclusion bodies iso- lated from E. coli incubated at different temperatures: 25°C  (c), 37°C (d) and 42°C (e) Figure 1
FT-IR spectra in Amide I and Amide II regions of ammonium 
sulfate precipitate of pure GFP (b), and inclusion bodies iso-
lated from E. coli incubated at different temperatures: 25°C 
(c), 37°C (d) and 42°C (e).
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The second derivatives of the spectra presented in Figure 1.
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FT-IR spectra in Amide I and Amide II regions of His7ΔN6  TNF-α in solution (a), as ammonium sulfate precipitate (b),  and in inclusion bodies isolated from E. coli incubated at dif- ferent temperatures: 25°C (c), 37°C (d) and 42°C (e) Figure 3
FT-IR spectra in Amide I and Amide II regions of His7ΔN6 
TNF-α in solution (a), as ammonium sulfate precipitate (b), 
and in inclusion bodies isolated from E. coli incubated at dif-
ferent temperatures: 25°C (c), 37°C (d) and 42°C (e).
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The second derivatives of the spectra presented in Figure 3.
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Extractability of proteins from IBs
As already described by Jevsevar [12] and Peternel [11,29],
G-CSF IBs prepared at 25°C are readily soluble in 0.2% N-
lauroyl sarcosine with almost 97% of G-CSF being dis-
solved. Slightly less protein can be extracted from GFP IBs
and His7dN6 TNF-α IBs (80 – 85%) (Figure 7). These pro-
teins, easily extractable from ncIBs, contain a higher per-
centage of correctly folded protein inside IBs (based on
spectroscopy analysis). This supports the hypothesis sug-
gested by Jevsevar at. al. [12] that the more alike the inner
structure of the IBs are the easier it is to extract the cor-
rectly folded protein from IBs.
On the other hand, the extractability of ΔN19LT-α from
IBs with 0.2% N-lauroyl sarcosine is significantly lower,
and only up to 40% of the target protein can be dissolved
(Figure 7). As can be seen from the infrared studies, the
percentage of unordered structures inside ΔN19LT-α IBs is
very high (even those formed at 25°C) and this could
explain the poor extractability of ΔN19LT-α from such
IBs.
In all cases, IBs prepared at higher temperatures (37°C,
42°C) are less soluble in 0.2% N-lauroyl sarcosine. The
lower solubility of IBs prepared at higher temperatures is
not surprising as IBs have been generally reported to be
insoluble in mild detergents. This is probably due to the
high percentage of unordered protein structures in the IBs
that was also confirmed by spectroscopy analysis.
Extractability of properly folded proteins from IBs in mild
detergents is a very interesting property. IBs are predomi-
nantly composed of the target protein. During protein
extraction in mild, non-denaturing conditions mainly
properly folded proteins are extracted. We might thus
speculate that during such extraction the target protein is
further enriched and therefore less downstream steps are
necessary to purify the protein. This hypothesis was con-
firmed during the preparation of the process for purifica-
FT-IR spectra in Amide I and Amide II regions of ΔN19 LT-α  inclusion bodies isolated from E. coli incubated at different  temperatures: 25°C (c), 37°C (d) and 42°C (e) Figure 5
FT-IR spectra in Amide I and Amide II regions of ΔN19 LT-α 
inclusion bodies isolated from E. coli incubated at different 
temperatures: 25°C (c), 37°C (d) and 42°C (e).
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The second derivatives of the spectra presented in Figure 5.
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SDS-PAGE analysis of proteins extracted from IBs with 0.2%  N-lauroyl sarcosine Figure 7
SDS-PAGE analysis of proteins extracted from IBs 
with 0.2% N-lauroyl sarcosine. Inclusion bodies were iso-
lated from E. coli cultivated at 25°C. 1 – BSA (Bovine serum 
albumin) standard 0.2 mg; 2 – BSA standard 0.88 mg; 3 – BSA 
standard 1.5 mg; 4 – total cell proteins; 5 – soluble (cytoplas-
mic) proteins; 6 – IBs proteins; 7 – IBs proteins extracted 
with 0.2% NLS; 8 – in 0.2% NLS insoluble IBs proteins; 9 – 
LMW standard.Microbial Cell Factories 2008, 7:34 http://www.microbialcellfactories.com/content/7/1/34
Page 7 of 9
(page number not for citation purposes)
tion of G-CSF, where, in a single chromatography step, the
production of a biologically active G-CSF with a purity
greater than 95% was achieved [30]. The same was also
achieved for the isolation of pure, biologically active, flu-
orescent GFP and His7dN6 TNF-α (unpublished results).
Here some interesting questions arise, such as whether the
IBs of other proteins produced at low temperatures are
also in the form of more soluble material containing eas-
ily extractable, correctly folded proteins. Since IBs usually
represent a highly concentrated pool of the target protein,
it is worth exploring the industrial potential of easily sol-
uble IBs, especially those containing large amounts of bio-
logically active protein, in order to reduce production
costs and to develop environmentally less harmful tech-
nologies. Such IBs composed of pure protein could also
be used as active nanoparticles in diagnostics or as biocat-
alysts in enzymatic processes or even as biopharmaceuti-
cals.
Biological activity
The specific biological activity of the protein was meas-
ured in two distinctive fractions: soluble protein produced
in the cytoplasm (SN1) and insoluble protein, solubilized
from IBs under mild non-denaturing conditions in 0.2%
N-lauroyl sarcosine (SN2). Biological activity was meas-
ured for all four studied proteins.
Almost 50% of G-CSF extracted from the IBs shows spe-
cific biological activity [11]. Since the majority of the
expressed G-CSF is in the form of IBs (98%), this repre-
sents almost all the biologically active protein produced
in the cell. From the remaining 2% of total GCSF, which
is produced in the cytoplasm, only 30% is in active form,
representing less than 1% of the total G-CSF (Table 2, Fig-
ure 8).
Altogether around 12% of the total GFP produced in bac-
terial cells is correctly folded and oxidized (fluorescent).
As previously reported by Garcia-Fruitos at al. [10], GFP
inside the IBs can be highly fluorescent. Our results show
that 6% of all GFP in IBs is in the active, fluorescent form.
Although the amount of active, fluorescent GFP in the
cytoplasm is higher (about 30%), the protein is predomi-
nantly produced in the insoluble fraction (77%). There-
fore, the share of the total GFP produced in the cell is
almost equally distributed between the soluble and insol-
uble fraction (Table 2, Figure 8). Based on the spectros-
copy analysis, we believe that the amount of correctly
folded protein inside IBs is even higher, but not all the
correctly folded protein is oxidized. Consequently not all
the correctly folded protein is fluorescent.
As in the case of GFP, around 5% of His7ΔN6 TNF-α
extracted from IBs is in biologically active form. Since
Distribution of target protein between the soluble fraction (cytoplasm) and insoluble fraction (IBs) is presented on pie dia- grams Figure 8
Distribution of target protein between the soluble fraction (cytoplasm) and insoluble fraction (IBs) is presented on pie dia-
grams. Percentages of specific biological activity of target proteins in each fraction are presented on column charts.Microbial Cell Factories 2008, 7:34 http://www.microbialcellfactories.com/content/7/1/34
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40% of the protein is produced inside IBs, this represents
2% of the total His7ΔN6 TNF-α produced in E. coli. Pro-
tein produced in the cytoplasm shows much higher bio-
logical activity (around 60%) and this corresponds to
36% of the total His7ΔN6 TNF-α produced in the cell.
Therefore we can conclude that correctly folded His7ΔN6
TNF-α is predominantly produced in the soluble fraction
(Table 2, Figure 8).
The specific biological activity of total ΔN19LT-α pro-
duced in bacterial cells is less than half the percentage of
that expected. The protein is mainly produced in the form
of IBs inside bacterial cells (91%). Since only 0.1% (Table
2, Figure 8) of the protein extracted from IBs is biologi-
cally active, we may conclude that IBs of dN19LT-α, even
when produced at 25°C, show typical characteristics of
classical inclusion bodies containing essentially dena-
tured and almost completely biologically inactive protein.
The results were also confirmed by infrared spectroscopy
(Figure 5 and 6), which revealed a high percentage of
unordered structure in ΔN19 LT-α IBs produced at low
temperature. Some specific biological activity was meas-
ured in the soluble protein fraction (3%), but even there
the amount of properly folded protein is very small.
Based on the results presented above, the properly folded
active protein can be produced inside the soluble (cyto-
plasm) and insoluble (IBs) cell fraction. The amount of
properly folded protein inside individual cell fractions
depends very much on the protein.
In the case of G-CSF, the active protein was predomi-
nantly produced inside the IBs. In addition, the amount of
active protein inside GFP and His7ΔN6 TNF-α IBs was sig-
nificant and IBs could be used the source for the extraction
of active protein. In the case of N19 LT-α, the amount of
properly folded protein inside IBs was trivial. Therefore
we can conclude that three of the four studied proteins
form IBs composed of a significant amount of properly
folded biologically active protein. As mentioned in a pre-
vious section, such IBs containing active proteins are very
interesting for research and medical purposes, as well as
for industrial use.
Once again it has to be stressed that specific biological
activity data discussed above were obtained for IBs pre-
pared at 25°C. When produced at higher temperatures
(37°C, 42°C), all the proteins showed almost no biolog-
ical activity. The same results were also obtained by infra-
red spectroscopy, where spectra of IBs produced at low
temperatures were very similar to the spectra of the pure
proteins, whereas IBs produced at higher temperatures
contain a high proportion of unordered structures.
Conclusion
In all cases studied so far, it was found that various
amounts of correctly folded proteins were trapped inside
inclusion bodies. The amount of correctly folded proteins
and the solubility of the inclusion bodies mainly depend
on the nature of the target protein, as well as on the
growth conditions, such as the temperature and induction
regime. Infrared spectroscopy analysis shows the presence
of correctly folded proteins inside IBs. However, it is not
possible to predict the biological activity of the target pro-
tein from spectroscopy analysis of the secondary protein
structure. Results show that even though spectroscopy
analysis shows a relatively high proportion of correctly
folded proteins inside IBs (in the case of GFP and
His7ΔN6 TNF-α at 37°C), very low solubility of IBs in
0.2% N-lauroyl sarcosine as well as almost no biological
activity can also be observed.
In our future work, we plan to optimize important param-
eters for the biosynthesis of proteins in the form of inclu-
sion bodies with the main goal of increasing the
accumulation of active protein inside the inclusion bod-
ies. This should enable efficient isolation of the active pro-
tein by gentle extraction under non-denaturing
conditions or even allow the use of IBs as active nanopar-
ticles.
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Table 2: Specific biological activity of the target protein regarding the total target protein produced in bacterial cell is presented. The 
distribution between soluble (cytoplasm) and insoluble (IBs) cell fraction is also presented.
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